SCM
LUNG icon

Stonepine Capital Management’s Pulmonx LUNG Stock Holding History

Stonepine Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
815,436
+47,148
+6% +$65K 0.6% 38
2026
Q1 		$991K Buy
768,288
+281,888
+58% +$466K 0.4% 34
2025
Q4 		$1.07M Sell
486,400
-183,600
-27% -$345K 0.78% 34
2025
Q3 		$1.09M Buy
670,000
+524,100
+359% +$1.1M 0.88% 26
2025
Q2 		$378K Buy
+145,900
New +$576K 0.37% 45

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Stonepine Capital Management's LUNG Position: Q2 2026 in Review

Stonepine Capital Management increased its Pulmonx (LUNG) stake by 6.1% in Q2 2026, buying an estimated $65K and bringing the position to 815,436 shares worth $1.06M. The position accounts for 0.6% of the portfolio, ranked #38.

Stonepine Capital Management first reported a position in LUNG in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.09M in Q3 2025. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Stonepine Capital Management held 815,436 shares of Pulmonx worth $1.06M as of Q2 2026.
  • Stonepine Capital Management bought 47,148 Pulmonx shares in Q2 2026, an estimated $65K.
  • Pulmonx made up 0.6% of Stonepine Capital Management's portfolio in Q2 2026, its #38 holding.
  • Stonepine Capital Management first reported a position in Pulmonx in Q2 2025 and has held it in 5 quarters since.
  • Stonepine Capital Management's Pulmonx position peaked at $1.09M in Q3 2025.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Stonepine Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.